Quantum BioPharma Ltd. Selling, General and Administrative Expense
Quantum BioPharma Ltd. (QNTM) reported Selling, General and Administrative Expense of $9.05 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2026-03-26
- Quantum BioPharma Ltd. selling general and administrative expense for the quarter ending 2025-12-31 was $1.37M, a 29.29% decline year-over-year.
- Quantum BioPharma Ltd. selling general and administrative expense for the quarter ending 2025-09-30 was $3.04M, a 6.42% decline year-over-year.
- Quantum BioPharma Ltd. selling general and administrative expense for the quarter ending 2025-06-30 was $3.31M, a 43.41% increase year-over-year.
- Quantum BioPharma Ltd. selling general and administrative expense for the quarter ending 2025-03-31 was $1.33M, a 30.80% decline year-over-year.
| Period end | Selling General And Administrative Expense 3 month | Selling General And Administrative Expense 6 month | Selling General And Administrative Expense 9 month | Selling General And Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.37M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $4.41M derived: sum of 2 quarters · filed 2026-03-26 | $7.72M derived: sum of 3 quarters · filed 2026-03-26 | $9.05M 20-F · filed 2026-03-26 |
| 2025-09-30 | $3.04M 6-K · filed 2025-11-06 | $6.35M derived: sum of 2 quarters · filed 2025-11-06 | $7.68M 6-K · filed 2025-11-06 | $9.61M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $3.31M 6-K · filed 2025-08-07 | $4.64M 6-K · filed 2025-08-07 | $6.57M derived: sum of 3 quarters · filed 2026-03-26 | $9.82M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | $1.33M 6-K/A · filed 2025-06-16 | $3.26M derived: sum of 2 quarters · filed 2026-03-26 | $6.51M derived: sum of 3 quarters · filed 2026-03-26 | $8.82M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $1.93M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $5.18M derived: sum of 2 quarters · filed 2026-03-26 | $7.49M derived: sum of 3 quarters · filed 2026-03-26 | $9.41M 20-F · filed 2026-03-26 |
| 2024-09-30 | $3.25M 6-K · filed 2025-11-06 | $5.56M derived: sum of 2 quarters · filed 2025-11-06 | $7.48M 6-K · filed 2025-11-06 | |
| 2024-06-30 | $2.31M 6-K · filed 2025-08-07 | $4.23M 6-K · filed 2025-08-07 | ||
| 2024-03-31 | $1.92M 6-K/A · filed 2025-06-16 | |||
| 2023-12-31 | $9.03M 20-F · filed 2026-03-26 |